Agenda
PHARMA R&D WORLD ASIA CONGRESS
17th – 18th January 2013, Shanghai, China
The 3rd Pharma R&D Asia Congress (www.pharmaworldasia-congress.com) will be held on the 17th & 18th January 2013 in Shanghai, China. The event will be co-located with our 2nd Annual Clinical Trials & Clinical Outsourcing Asia Congress (www.clinicalasia-congress.com),
The congress is the single most senior-level and focused event in Asia dedicated to innovative strategies and technologies in accelerating drug discovery research and later-stage drug development. It also provides insights into the R&D in Drug Development, Bisimilars and Biologics Development. Do not miss out on the opportunity to forge partnerships between pharma companies, biopharma companies and research institutions in the Asia market.
Over two days, the congress will attract over 150 senior-level decision makers working in Discovery, Early Development, R&D Outsourcing, R&D, Translational Sciences and Biomarkers from pharma, biotech companies , academic institutions and healthcare Institutes in China, Singapore, India, Japan, Korea, Thailand, Malaysia. Prominent key leaders from Europe and US will also be represented to foster knowledge sharing, networking and R&D partnerships.
R&D World Asia Congress – Key topics include:
Day 1 Stream 1 :
Pharma R&D Trends & Outsourcing Strategies in Asia
- Executive VP Panel Discussions on :
- Partnership and Alliances
- Key trends in Research & Development
- Pharmaceutical M&A in the Asia-Pacific Region – mainly in China, India & Japan
- Innovation-Oriented Pharma R&D Activities in Asia
- Trends in the CRO sectors in China, India and Japan
Biologics Discovery and Development
- Biosimilars and Biobetters Development
- Biological Discovery and Development strategies, R&D and Business Models
Day 2 Stream 1 :
Drug Development in Oncology and Other Therapeutic Areas in China and other APAC Regions
Biomarkers and Personalised Medicine
- Identifying Novel Targets in Disease Biomarker Discovery
- Translational Strategies for Therapeutics Discovery & Development
- Overcoming Challenges in the Identification and Validation of Biomarkers
- Translational Imaging Biomarkers
- Implementing Biomarkers in Pre-clinical and Clinical Development
- Oncology Biomarkers Clinical Strategy
Co-located Clinical Trials and Outsourcing Congress – Key topics include:
- VPs and Directors Panel Discussions on:
- Drug Development Activities and Managing Clinical Development in Asia
- Clinical Outsourcing Strategies from CRO and Pharma Companies point of view
Day 1
Clinical Development Activities and Managing Clinical Development in Asia
- Building long term partnerships and goals
- Managing safety in the clinical development process
- Overcoming challenges in pharma and emerging biotechs in Asia
Clinical Research Outsourcing Strategies
- Outsourcing and partnership strategies – Drug Development
- New Trends in Global Clinical Trials and the Role in China, India and Emerging Countries in Europe
- Collaborating with Academic Research Organizations
- Managing Clinical Trials : Patient Recruitment and Patient Retention
- Country and Site Selection for Global Clinical Trials and Clinical Trials Management Strategies
- Patient recruitment to sample data analysis
- Regulatory approval and processes in Asia
- Monitoring of clinical trials throughout the Asia and Asia Pacific region
- Maintaining relationships with investigators and regulators as core capabilities
Day 2
Implementing Clinical Trials in China, India, Korean, Japan and Asia Pacific Regions
Clinical Development and Clinical Trials in Oncology and other Therapeutic Areas in China and other APAC Regions
- Biomarkers in Clinical Development and Diagnostics Development
- Trials Design and Implementing Oncology Trials
